Background Image
Table of Contents Table of Contents
Previous Page  102 / 102
Information
Show Menu
Previous Page 102 / 102
Page Background

Dyna Indapamide SR.

Each sustained release tablet contains 1,5 mg indapamide. Reg. No.: RSA S3 A42/7.1/0790. NAM NS2 12/7.1/0138. For full prescribing information, refer to the package insert approved by the

Medicines Control Council, 25 November 2011.

1)

Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drug Safety 2001;24(15):1155-1165.

2)

Department of Health website.

http://

www.mpr.gov.za

– Accessed 06/06/2016.

DIND223/07/2016.

For further product information contact

PHARMA DYNAMICS

P O Box 30958 Tokai Cape Town 7966

Tel

021 707 7000

Fax

021 701 5898

Email

info@pharmadynamics.co.za

CUSTOMER CARE LINE

0860 PHARMA (742 762)

www.pharmadynamics.co.za

SUSTAINED

RELEASE

METABOLICALLY

NEUTRAL

1

A Lupin Group Company

only generic

1,5 mg

sustained release

formulation

R33

,19

2

Printed by Tandym Printers